Rigel Pharmaceuticals (RIGL) Prepaid Assets (2010 - 2026)
Rigel Pharmaceuticals (RIGL) recorded quarterly Prepaid Assets of $25.7 million in Q1 2026, up 394.45% quarter-over-quarter from $5.2 million in Q4 2025, and up 10.7% on a YoY basis from $23.3 million in Q1 2025.
Rigel Pharmaceuticals (RIGL) Prepaid Assets (2010 - 2026) Analysis & Trends
Rigel Pharmaceuticals' Prepaid Assets history runs 17 years deep, the most recent figure standing at $25.7 million for Q1 2026.
- In Q1 2026, Prepaid Assets rose 10.7% year-over-year to $25.7 million; the TTM figure through Mar 2026 stood at $25.7 million (up 10.7% YoY), while the FY2025 annual figure was $5.2 million, up 15.12% from the prior year.
- Prepaid Assets was $25.7 million for Q1 2026 at Rigel Pharmaceuticals, up from $5.2 million in the prior quarter.
- In the past five years, Prepaid Assets ranged from a high of $25.7 million in Q1 2026 to a low of $3.0 million in Q3 2023.
- Historically, Prepaid Assets has averaged $9.7 million across 5 years, with a median of $7.9 million in 2022.
- The sharpest annual moves came in 2023 and 2024: Prepaid Assets plunged 51.03% in 2023, then surged 231.48% in 2024.
- A 5-year view of Prepaid Assets shows it stood at $8.3 million in 2022, then retreated by 24.19% to $6.3 million in 2023, then dropped by 27.76% to $4.5 million in 2024, then rose by 15.12% to $5.2 million in 2025, then jumped by 394.45% to $25.7 million in 2026.
- The last three Prepaid Assets figures came in at $25.7 million (Q1 2026), $5.2 million (Q4 2025), and $18.6 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Rigel Pharmaceuticals | 603.18 Mn | 456.49 Mn | 54.21 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 25.75 Mn |
| Dec 31, 2025 | 5.21 Mn |
| Sep 30, 2025 | 18.56 Mn |
| Jun 30, 2025 | 5.44 Mn |
| Mar 31, 2025 | 23.26 Mn |
| Dec 31, 2024 | 4.52 Mn |
| Sep 30, 2024 | 9.99 Mn |
| Jun 30, 2024 | 8.66 Mn |
| Mar 31, 2024 | 8.85 Mn |
| Dec 31, 2023 | 6.26 Mn |
| Sep 30, 2023 | 3.02 Mn |
| Jun 30, 2023 | 4.97 Mn |
| Mar 31, 2023 | 7.87 Mn |
| Dec 31, 2022 | 8.26 Mn |
| Sep 30, 2022 | 6.16 Mn |
| Jun 30, 2022 | 7.94 Mn |
| Mar 31, 2022 | 9.42 Mn |
| Dec 31, 2021 | 7.41 Mn |
| Sep 30, 2021 | 5.93 Mn |
| Jun 30, 2021 | 6.61 Mn |